-
Featured Authors
-
Archives
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: Immunotherapy
WSJ: A Piece of the Immunotherapy Puzzle Solved
Just two weeks ago, the New York Times published a series of articles deeming immunotherapy as the future for cancer advances and new life-saving treatments – even though it’s not entirely clear why only some patients have success with the treatments. This week, the Wall Street Journal joined the immunotherapy conversation by highlighting two researchers who may have unlocked part of the mystery as to why only some patients benefit from immunotherapy. When Dr. Michael Read More >
ICYMI: NYT Chronicles Advances in Cancer Landscape Due to Immunotherapy
This week, the New York Times published a series of articles titled Cell Wars which explores the novel uses of immunotherapy to combat cancer. Patient stories were shared where immunotherapy cured them of lung, prostate, liver, and brain cancer. Included were stories of researchers who have dedicated their lives to finding new treatments and cures. As the article states, there is a new era of optimism — a sense that they have begun tapping into a force of Read More >
The Power of Innovation
Today’s “Fox and Friends” included an informative segment about the staggering advances being made in cancer care thanks to new and forthcoming innovative treatments. The segment featured five doctors from the Sarah Cannon Research Institute, a Nashville-based research organization that partners with biopharmaceutical companies to offer more than 500 clinical trials annually. “Over 40 years since President Nixon declared the War on Cancer, and after decades of giving more drugs and more radiation, we’re now Read More >
T-Cell Therapies: Best Bets in Pushing Down the Cost Curve and Prioritizing Cancer Targets
New approaches in cancer immunology are achieving promising early-stage results through novel techniques for arming the body’s own t-cells to have greater impact on reducing tumors and preventing the spread of disease. CAR-T methods that extract, reengineer, and reintroduce a given patient’s t-cells provide highly personalized therapy but may be difficult to scale up. The interleukin enhancement approach motivates existing t-cells to be more effective and may be easier to deliver but have less pervasive Read More >
Excerpts From Top Ten Current Science Trends Talk
For the opening day of BIO 2014, BioTech Primer delivered a talk on the Top 10 Current Science Trends, Issues, & Advances. Three of the technologies covered are highlighted below. Genome Editing: We often refer to a person’s genome – his complete set of genes – as a blueprint for life. But sometimes there are errors in this blueprint. Wouldn’t it be great if we could edit the blueprint and correct these errors? We might Read More >
